Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
The British Journal of Nutrition
|
August 29, 2023
<i>Rhodiola rosea</i> as an adaptogen to enhance exercise performance: a review of the literature
Grant M Tinsley, Andrew R Jagim, Gregory D M Potter, et al.
Current Surgery
|
January 1, 1987
Peripherally delivered renin supports reflex adrenal catecholamine secretion in anephric dogs
D G Koivunen, J F Seaton, S S Scaer, et al.
Endocrine Reviews
|
October 21, 2016
Circadian Rhythm and Sleep Disruption: Causes, Metabolic Consequences, and Countermeasures
Gregory D M Potter, Debra J Skene, Josephine Arendt, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
November 5, 1999
The immunotherapeutic potential of activated canine alveolar macrophages and antitumor monoclonal antibodies in metastatic canine melanoma
S A Soergel, E G MacEwen, D M Vail, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 1998
Preclinical evaluation of 5-iodo-2-pyrimidinone-2'-deoxyribose as a prodrug for 5-iodo-2'-deoxyuridine-mediated radiosensitization in mouse and human tissues
T J Kinsella, K A Kunugi, K A Vielhuber, et al.
Neurology
|
January 19, 2011
Phase I trial of pegylated interferon-alpha-2b in young patients with plexiform neurofibromas
R I Jakacki, E Dombi, D M Potter, et al.
The Journal of Urology
|
August 23, 2000
Clinical usefulness of the novel marker BLCA-4 for the detection of bladder cancer
B R Konety, T S Nguyen, G Brenes, et al.
Journal of Leukocyte Biology
|
June 7, 2002
Flt-3 ligand (FL) drives differentiation of rat bone marrow-derived dendritic cells expressing OX62 and/or CD161 (NKR-P1)
Cynthia S Brissette-Storkus, J C Kettel, T F Whitham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 8, 2001
Pharmacodynamic model of topotecan-induced time course of neutropenia
W C Zamboni, D Z D'Argenio, C F Stewart, et al.
Reproductive Toxicology (Elmsford, N.Y.)
|
August 9, 2022
Lack of direct bone effect of tofacitinib, a JAK inhibitor, in juvenile rats and evaluation of the association between offspring growth and femur length
S N Campion, D M Potter, C J Bowman, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
The British Journal of Nutrition
|
August 29, 2023
<i>Rhodiola rosea</i> as an adaptogen to enhance exercise performance: a review of the literature
Grant M Tinsley, Andrew R Jagim, Gregory D M Potter, et al.
Current Surgery
|
January 1, 1987
Peripherally delivered renin supports reflex adrenal catecholamine secretion in anephric dogs
D G Koivunen, J F Seaton, S S Scaer, et al.
Endocrine Reviews
|
October 21, 2016
Circadian Rhythm and Sleep Disruption: Causes, Metabolic Consequences, and Countermeasures
Gregory D M Potter, Debra J Skene, Josephine Arendt, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
November 5, 1999
The immunotherapeutic potential of activated canine alveolar macrophages and antitumor monoclonal antibodies in metastatic canine melanoma
S A Soergel, E G MacEwen, D M Vail, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 1998
Preclinical evaluation of 5-iodo-2-pyrimidinone-2'-deoxyribose as a prodrug for 5-iodo-2'-deoxyuridine-mediated radiosensitization in mouse and human tissues
T J Kinsella, K A Kunugi, K A Vielhuber, et al.
Neurology
|
January 19, 2011
Phase I trial of pegylated interferon-alpha-2b in young patients with plexiform neurofibromas
R I Jakacki, E Dombi, D M Potter, et al.
The Journal of Urology
|
August 23, 2000
Clinical usefulness of the novel marker BLCA-4 for the detection of bladder cancer
B R Konety, T S Nguyen, G Brenes, et al.
Journal of Leukocyte Biology
|
June 7, 2002
Flt-3 ligand (FL) drives differentiation of rat bone marrow-derived dendritic cells expressing OX62 and/or CD161 (NKR-P1)
Cynthia S Brissette-Storkus, J C Kettel, T F Whitham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 8, 2001
Pharmacodynamic model of topotecan-induced time course of neutropenia
W C Zamboni, D Z D'Argenio, C F Stewart, et al.
Reproductive Toxicology (Elmsford, N.Y.)
|
August 9, 2022
Lack of direct bone effect of tofacitinib, a JAK inhibitor, in juvenile rats and evaluation of the association between offspring growth and femur length
S N Campion, D M Potter, C J Bowman, et al.
Page
of 4